| Amulya T Siram, MD | |
|
10 Members Way, Suite 400, Dover, NH 03820-5933 | |
| (603) 742-1143 | |
| (603) 749-3509 |
| Full Name | Amulya T Siram |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 19 Years |
| Location | 10 Members Way, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447424817 | NPI | - | NPPES |
| 3076445 | Medicaid | NH | |
| 1447424817 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 14903 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| Huggins Hospital | Wolfeboro, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wentworth Douglass Physician Corporation | 5496749848 | 372 |
News Archive
In a study with potentially major implications for the future treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody-making cells that cause an autoimmune disease, without harming the rest of the immune system.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.
Among other issues making news in the health care reform debate are people's weight, benefits for homosexual partners, the debate over interstate insurance and the timeline for implementing any changes.
A neutral-pressure IV needleless connector was associated with complete elimination of catheter-related bloodstream infections (CRBSI) in a successful device trial at a large cancer center in the six-month period following implementation of the device.
New England Biolabs (NEB) has introduced Lemo21(DE3) Competent E. coli, a tunable T7 expression strain optimized for the expression of difficult constructs, including membrane proteins, toxic proteins and proteins prone to insoluble expression.
› Verified 8 days ago
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
In a study with potentially major implications for the future treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody-making cells that cause an autoimmune disease, without harming the rest of the immune system.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.
Among other issues making news in the health care reform debate are people's weight, benefits for homosexual partners, the debate over interstate insurance and the timeline for implementing any changes.
A neutral-pressure IV needleless connector was associated with complete elimination of catheter-related bloodstream infections (CRBSI) in a successful device trial at a large cancer center in the six-month period following implementation of the device.
New England Biolabs (NEB) has introduced Lemo21(DE3) Competent E. coli, a tunable T7 expression strain optimized for the expression of difficult constructs, including membrane proteins, toxic proteins and proteins prone to insoluble expression.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amulya T Siram, MD 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 742-1143 | Amulya T Siram, MD 10 Members Way, Suite 400, Dover, NH 03820-5933 Ph: (603) 742-1143 |
News Archive
In a study with potentially major implications for the future treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody-making cells that cause an autoimmune disease, without harming the rest of the immune system.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.
Among other issues making news in the health care reform debate are people's weight, benefits for homosexual partners, the debate over interstate insurance and the timeline for implementing any changes.
A neutral-pressure IV needleless connector was associated with complete elimination of catheter-related bloodstream infections (CRBSI) in a successful device trial at a large cancer center in the six-month period following implementation of the device.
New England Biolabs (NEB) has introduced Lemo21(DE3) Competent E. coli, a tunable T7 expression strain optimized for the expression of difficult constructs, including membrane proteins, toxic proteins and proteins prone to insoluble expression.
› Verified 8 days ago
Dr. Mark Lee Dick, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 | |
Mrs. Jhansi Lakshmi Maradana, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Ravi Teja Pasam, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2503 Fax: 603-740-2497 | |
Paul C Tung, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 10 Members Way, Suite 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Amy Claire Bessnow, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2694 | |
Dylan Thomas, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Alison M Sollee, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 |